Evaluation of diagnostics of endobronchial tumor pathology using a narrow spectrum imaging system

Modern medicine has new equipment and high-tech diagnostic methods. At the same time, when using standard X-ray endoscopic diagnostic methods, 70-80% of newly diagnosed patients with lung cancer have stage III-IV disease. Among the radiation methods of examination for detecting lung cancer, fluorography, chest radiography, and computed tomography are used. The main disadvantage for diagnosing lung cancer is the low level of sensitivity and accuracy, and the proportion of false-positive and false-negative conclusions reaches 30%. According to AJCC recommendations, chest radiography is not recommended for lung cancer screening due to its low efficiency. Computed tomography is recommended for screening in risk groups. However, CT reveals tumor lesions already at the stage of peripheral lymphadenopathy. Modern bronchological examination is the main method for detecting hidden, early forms of lung cancer in the diagnosis.